Imaging Nerd - Radiology Made Simple

Key Points

CTA and MRA both make blood look bright so vessels pop out from everything around them — they just use different tricks to get there.
The single hardest part of CTA isn't the scan, it's timing: you have to catch the contrast in the artery during the few seconds it's actually there.
Bolus tracking and timing-bolus are the two ways we solve that timing problem; both watch for contrast to arrive, then fire.
MRA can make vessels bright with no injected contrast at all (time-of-flight), or with gadolinium for cleaner, faster coverage.
Pick the protocol around the question: which vessel, how fast does it move, and can the patient hold still and hold their breath.

A blood vessel is, optically speaking, a deeply unremarkable gray tube buried in a lot of other gray tubes. The whole job of a CT angiogram (CTA) or MR angiogram (MRA) is to briefly make that tube glow so you can trace it, measure it, and decide whether it's about to ruin someone's day. The protocol is just the recipe for the glow.

The CTA problem is a timing problem

Here's the thing nobody warns you about: in CTA, the scanner is fast and the contrast is fleeting. Iodinated contrast is injected into an arm vein, travels to the heart, gets pumped out, and lights up the arteries for a handful of seconds before it drains into veins and tissue. Scan too early and the artery is still gray. Scan too late and you've photographed the veins instead — technically a picture, just the wrong one.

So a CTA is a race. You want the scanner sweeping through the body at the exact moment the contrast is packed into the artery of interest, like trying to photograph a train as it passes one specific window. Miss the window, miss the train.

Note

We talk about "arterial phase" versus "venous phase" for exactly this reason. CTA lives in the arterial phase — that brief moment when arteries are bright and veins haven't filled yet. For more on how the iodine actually creates that brightness, see iodinated contrast.

Two ways to catch the train: bolus tracking and timing bolus

We don't guess. We measure. There are two standard ways to nail the timing:

Method	How it works	Best when
Bolus tracking	Park a little measuring spot (a "region of interest") on the target vessel, scan it repeatedly at low dose, and auto-trigger the real scan the instant brightness crosses a threshold.	Most CTAs — it adapts to this patient's circulation in real time.
Timing bolus	Inject a tiny test dose first, watch how many seconds it takes to arrive, then time the full scan to match.	When you want a precise delay or the anatomy makes tracking tricky.

Bolus tracking is the workhorse because it doesn't care that your patient has a sluggish heart or a brisk one — it simply waits for the contrast to actually show up, then goes. A timing bolus spends a little extra contrast to learn the travel time up front.

Figure · CT

Bolus-tracking setup for a chest CTA: axial image at the level of the proximal descending aorta with a circular region-of-interest cursor placed in the aortic lumen, plus the time-attenuation curve showing enhancement climbing past the trigger threshold.

The other knobs: injection rate, kV, and coverage

A few dials shape every CTA:

Injection rate. Fast injection (a higher mL/sec through a good IV) gives a tighter, brighter bolus — important for arteries that empty quickly. This is why a CTA needs a sturdier IV than a routine scan.
Tube voltage (kV). Iodine glows more dramatically at lower kV, so vascular protocols often drop the kV to make vessels brighter while also trimming dose.
Thin slices. Vessels are small and curvy, so CTAs are reconstructed thin, then reformatted into the pretty 3D and curved views surgeons love.

Clinical Pearl

The most common CTA failure I see isn't a scanner problem — it's a bad IV. A small or leaky line can't deliver contrast fast enough, the bolus arrives soft and dim, and the artery never gets bright. Garbage in, gray vessels out.

MRA: same goal, different magic

MRA chases the same prize — bright vessels — but MRI gives it two routes.

Contrast-enhanced MRA uses gadolinium, which shortens T1 and makes flowing blood blaze on a fast T1 sequence. Like CTA, it's timing-dependent: you fire as the gadolinium fills the target arteries.

Non-contrast MRA is the genuinely clever one. Time-of-flight (TOF) exploits motion itself: stationary tissue gets hit with repeated pulses until it's "saturated" and dull, while fresh blood flowing into the slice is still bright and unsaturated. The vessels glow simply because the blood inside them is moving — no needle required. The deeper physics of how these flow-sensitive sequences are built lives over in common MRI sequences.

Good to Know

The headline advantage of non-contrast MRA: no iodine, no gadolinium, no IV race against the clock. That's a real gift in patients with poor kidney function, where we'd rather not give contrast at all.

Which one, when

There's no universal winner — it's horses for courses:

CTA is fast, widely available, exquisitely detailed, and the go-to in emergencies — think suspected aortic dissection, aneurysm, or pulmonary embolism, where minutes matter and you need the whole vascular map now.
MRA trades speed for no ionizing radiation and (with TOF) no contrast, making it attractive for surveillance, younger patients, and contrast-cautious situations — as long as the patient can hold reasonably still.

Pitfall

TOF MRA has a sneaky trap: slow or turbulent flow can look like a narrowing or blockage that isn't real, because sluggish blood gets partly saturated and dims out. So a TOF "stenosis" can overcall the disease. When the stakes are high, correlate with another technique before you call a vessel occluded.

The one thing to carry out